Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Sio Capital Management, LLC (CIK 1482416) reported $604.3M across 57 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: AVR ($54.6M, 9.04%), COR ($49.1M, 8.13%), MMS ($38.5M, 6.36%), ALLO ($27.7M, 4.59%), GMED ($23.8M, 3.95%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $54.6M | 9.04% | 5.5M | Added |
| 2 | COR | CENCORA INC | $49.1M | 8.13% | 173,588 | Added |
| 3 | MMS | MAXIMUS INC | $38.5M | 6.36% | 715,267 | Trimmed |
| 4 | ALLO | ALLOGENE THERAPEUTICS INC | $27.7M | 4.59% | 13.3M | New |
| 5 | GMED | GLOBUS MED INC | $23.8M | 3.95% | 301,816 | New |
| 6 | GSK | GSK PLC | $22.9M | 3.79% | 436,700 | Added |
| 7 | TYRA | TYRA BIOSCIENCES INC | $22.2M | 3.68% | 695,315 | Added |
| 8 | WAY | WAYSTAR HLDG CORP | $19.0M | 3.15% | 925,834 | Trimmed |
| 9 | SLS | SELLAS LIFE SCIENCES GROUP I | $18.2M | 3.01% | 1.2M | New |
| 10 | IDYA | IDEAYA BIOSCIENCES INC | $17.9M | 2.96% | 480,383 | New |
| 11 | ORKA | ORUKA THERAPEUTICS INC | $16.9M | 2.79% | 177,118 | Added |
| 12 | CI | THE CIGNA GROUP | $15.9M | 2.63% | 57,750 | New |
| 13 | SNY | SANOFI SA | $15.5M | 2.57% | 364,200 | Added |
| 14 | ICLR | ICON PUB LTD CO | $15.3M | 2.53% | 88,186 | Trimmed |
| 15 | VTRS | VIATRIS INC | $15.2M | 2.51% | 954,299 | New |
| 16 | CCRN | CROSS CTRY HEALTHCARE INC | $14.5M | 2.40% | 1.1M | Hold |
| 17 | RAPP | RAPPORT THERAPEUTICS INC | $12.8M | 2.12% | 307,657 | Trimmed |
| 18 | ABT | ABBOTT LABORATORIES | $11.7M | 1.93% | 128,656 | Trimmed |
| 19 | CELC | CELCUITY INC | $11.5M | 1.90% | 110,022 | Trimmed |
| 20 | ZBH | ZIMMER BIOMET HOLDINGS INC | $11.3M | 1.87% | 131,445 | Added |
| 21 | REGN | REGENERON PHARMACEUTICALS | $11.2M | 1.86% | 18,000 | New |
| 22 | BMY | BRISTOL-MYERS SQUIBB CO | $11.1M | 1.85% | 193,500 | New |
| 23 | MDT | MEDTRONIC PLC | $11.1M | 1.84% | 142,500 | New |
| 24 | VIR | VIR BIOTECHNOLOGY INC | $11.0M | 1.81% | 1.1M | Trimmed |
| 25 | SENS | SENSEONICS HLDGS INC | $9.0M | 1.50% | 1.6M | Added |
Source: SEC Form 13F filings · as of 2026-06-30